Experiments for taxon Chrysosplenium grayanum (SAXIFRAGACEAE)

57 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
142049	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116635	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	BRICKELLIN
142065	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116633	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	RETUSIN
142043	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116628	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL D
142054	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
147708	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOSIDE H
142061	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142050	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
1138985	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
142045	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116621	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
142056	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142067	PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTITUMOR ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142055	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142066	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142062	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142051	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
586331	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
116632	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	RETUSIN
147707	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOGRAYANONE
116627	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL B
134843	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOGRAYANONE
1138984	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
142040	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142048	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142059	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116624	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL G
116622	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL F
142044	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116636	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	BENZOIC ACID,3-5-DIHYDROXY-4-METHOXY: METHYL ESTER
1138987	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
116631	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL E
142041	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116619	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
116626	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL B
142052	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142063	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116623	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL F
142058	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142047	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116629	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL D
116634	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	BRICKELLIN
116618	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
142060	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142042	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
142064	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116637	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	BENZOIC ACID,3-5-DIHYDROXY-4-METHOXY: METHYL ESTER
142053	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
147706	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOQUINONE A
142057	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:
116625	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL G
116630	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chrysosplenium grayanum (SAXIFRAGACEAE)	CHRYSOSPLENOL E
1138986	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
116620	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)
142046	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chrysosplenium grayanum (SAXIFRAGACEAE)	PELTOBOYKINOLIC ACID,BETA:

Experiments for taxon Chrysosplenium grayanum (SAXIFRAGACEAE)

Experiments (57 results)

Filters

Worktypes (17)

Pharmacology (4)

Compounds (13)

Organisms (7)